Targeting TEAD/YAP-transcription-dependent necrosis, TRIAD, ameliorates Huntington’s disease pathologyYingwei Mao, Hitoshi Okazawa, Kazumi Motoki et al.|Human Molecular Genetics|2016Cited by 50
Identification of hepta-histidine as a candidate drug for Huntington’s disease by in silico-in vitro- in vivo-integrated screens of chemical librariesTomomi Imamura, Hitoshi Okazawa, Kyota Fujita et al.|Scientific Reports|2016Cited by 15